SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 21.12 |
Enterprise Value ($M) | 7.83 |
Book Value ($M) | 16.49 |
Book Value / Share | 0.50 |
Price / Book | 1.28 |
NCAV ($M) | 16.49 |
NCAV / Share | 0.50 |
Price / NCAV | 1.28 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.17 |
Return on Assets (ROA) | 0.78 |
Return on Equity (ROE) | 36.04 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 8.52 |
Current Ratio | 8.52 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 18.91 |
Assets | 18.91 |
Liabilities | 2.42 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -16.83 |
Net Income | 2.78 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -27.18 |
Cash from Investing | -0.00 |
Cash from Financing | 27.88 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Armistice Capital, Llc | 7.68 | -5.99 | |
13G/A | Great Point Partners Llc | 9.99 | 10.89 | |
13G/A | Sclar Jeremy M. | 19.10 | 77.92 | |
13G/A | Gordon Michael S | 14.00 | 77.07 | |
13G | Shaf QIC LLC | 9.99 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
56,818 | 87,285 | 65.09 | |
2,080 | 11,473 | 18.13 | |
338 | 6,012 | 5.62 | |
(click for more detail) |
Similar Companies | |
---|---|
PHIO – Phio Pharmaceuticals Corp. | PLUR – Pluri Inc. |
PMCB – PharmaCyte Biotech, Inc. | PRFX – PainReform Ltd. |
PROK – ProKidney Corp. |
Financial data and stock pages provided by
Fintel.io